scholarly journals Plasma Cholesterol Reduction Effect of FR129169 in The Rat.

1993 ◽  
Vol 61 ◽  
pp. 124
Author(s):  
Yuri Sakuma ◽  
Akira Nagayoshi ◽  
Hiroyuki Hagihara ◽  
Yoshitada Notsu ◽  
Takaharu Ono
Hypertension ◽  
2000 ◽  
Vol 36 (suppl_1) ◽  
pp. 683-683
Author(s):  
Ralf Dechend ◽  
Anette Fiebeler ◽  
Joon-Keun Park ◽  
Dominik N Muller ◽  
Jurgen Theuer ◽  
...  

32 HMG-CoA reductase inhibitors have effects that extend beyond cholesterol reduction. We used an angiotensin (Ang) II-dependent model to test the hypothesis that cerivastatin ameliorates cardiac injury. We treated rats transgenic for human renin and angiotensinogen (dTGR) chronically from week 4 to 7 with cerivastatin (0.5 mg/kg/d by gavage). We used immunohistochemistry, electrophoretic mobility shift assays, and RT-PCR techniques. Compared to control dTGR, dTGR treated with cerivastatin had reduced mortality, blood pressure, cardiac hypertrophy, macrophage infiltration, and collagen I and IV deposition. Total plasma cholesterol was not different between the groups. Immunohistochemical analysis showed increased expression of basic fibroblast growth factor (b-FGF), IL-6, and the NF-κB subunit p65 in the media of dTGR, which was markedly reduced by cerivastatin. b-FGF mRNA in the left ventricle was also significantly reduced. The transcription factors NF-κB and AP-1 were substantially less activated in the left ventricle. These results suggest that statins ameliorate Ang II-induced hypertension, cardiac hypertrophy, and remodeling, independent of cholesterol reduction. They suggest that statins interfere with Ang II-induced signaling and transcription factor activation, thereby ameliorating end-organ damage.


Metabolism ◽  
1988 ◽  
Vol 37 (8) ◽  
pp. 752-757 ◽  
Author(s):  
Guido Franceschini ◽  
Paola Apebe ◽  
Laura Calabresi ◽  
Ghil Busnach ◽  
Luigi Minetti ◽  
...  

2008 ◽  
Vol 22 (S1) ◽  
Author(s):  
Yun‐Jeong Hong ◽  
Yookyung Kim ◽  
Maciej Turowski ◽  
Kerr Anderson ◽  
Wallace Yokoyama

2013 ◽  
Vol 110 (8) ◽  
pp. 1394-1401 ◽  
Author(s):  
Cinzia Parolini ◽  
Stefano Manzini ◽  
Marco Busnelli ◽  
Elena Rigamonti ◽  
Marta Marchesi ◽  
...  

Many functional foods and dietary supplements have been reported to be beneficial for the management of dyslipidaemia, one of the major risk factors for CVD. Soluble fibres and legume proteins are known to be a safe and practical approach for cholesterol reduction. The present study aimed at investigating the hypocholesterolaemic effect of the combinations of these bioactive vegetable ingredients and their possible effects on the expression of genes regulating cholesterol homeostasis. A total of six groups of twelve rats each were fed, for 28 d, Nath's hypercholesterolaemic diets, differing in protein and fibre sources, being, respectively, casein and cellulose (control), pea proteins and cellulose (pea), casein and oat fibres (oat), casein and apple pectin (pectin), pea proteins and oat fibres (pea+oat) and pea proteins and apple pectin (pea+pectin). Administration of each vegetable-containing diet was associated with lower total cholesterol concentrations compared with the control. The combinations (pea+oat and pea+pectin) were more efficacious than fibres alone in modulating cholesterolaemia ( − 53 and − 54 %, respectively, at 28 d; P< 0·005). In rats fed the diets containing oat fibres or apple pectin, alone or in combination with pea proteins, a lower hepatic cholesterol content (P< 0·005) and higher hepatic mRNA concentrations of CYP7A1 and NTCP were found when compared with the control rats (P< 0·05). In summary, the dietary combinations of pea proteins and oat fibres or apple pectin are extremely effective in lowering plasma cholesterol concentrations in rats and affect cellular cholesterol homeostasis by up-regulating genes involved in hepatic cholesterol turnover.


Sign in / Sign up

Export Citation Format

Share Document